File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/0020-7292(94)90459-6
- Scopus: eid_2-s2.0-0028168038
- PMID: 7813749
- WOS: WOS:A1994PN51000007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Malignant mixed Mullerian tumors of the uterus
Title | Malignant mixed Mullerian tumors of the uterus |
---|---|
Authors | |
Keywords | Malignant Mixed Mullerian Tumors Prognosis Uterus |
Issue Date | 1994 |
Publisher | Elsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/ijgo |
Citation | International Journal Of Gynecology And Obstetrics, 1994, v. 47 n. 1, p. 39-44 How to Cite? |
Abstract | Objective: To review the prognostic factors of Chinese women with mixed Mullerian tumors of the uterus. Method. A retrospective review of 21 cases of malignant mixed Mullerian tumors of the uterus treated during the 10-year period from 1980 to 1990. Results: All patients except one were postmenopausal. The incidence of previous pelvic irradiation was 9.5%. The most common presenting symptom was abnormal vaginal bleeding. One-third of patients yielded an abnormal cervical smear. Treatment included surgery, chemotherapy and radiotherapy in the majority of patients. Prognosis was poor with only three long-term survivors, all with stage-I homologous tumors with superficial myometrial invasion. The survival rate for stage-I and -II disease at 2 years was 50% and for more advanced disease extending beyond the uterus was 0%. The survival rate for all stages at 5 years was 14.3%, and the cumulative probability of survival at 5 years was 0.165. Conclusion: The most important prognostic factors appear to be the extent of tumor involvement at the time of diagnosis and the depth of myometrial invasion. |
Persistent Identifier | http://hdl.handle.net/10722/173203 |
ISSN | 2023 Impact Factor: 2.6 2023 SCImago Journal Rankings: 0.951 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | To, WWK | en_US |
dc.contributor.author | Ngan, HYS | en_US |
dc.date.accessioned | 2012-10-30T06:28:30Z | - |
dc.date.available | 2012-10-30T06:28:30Z | - |
dc.date.issued | 1994 | en_US |
dc.identifier.citation | International Journal Of Gynecology And Obstetrics, 1994, v. 47 n. 1, p. 39-44 | en_US |
dc.identifier.issn | 0020-7292 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/173203 | - |
dc.description.abstract | Objective: To review the prognostic factors of Chinese women with mixed Mullerian tumors of the uterus. Method. A retrospective review of 21 cases of malignant mixed Mullerian tumors of the uterus treated during the 10-year period from 1980 to 1990. Results: All patients except one were postmenopausal. The incidence of previous pelvic irradiation was 9.5%. The most common presenting symptom was abnormal vaginal bleeding. One-third of patients yielded an abnormal cervical smear. Treatment included surgery, chemotherapy and radiotherapy in the majority of patients. Prognosis was poor with only three long-term survivors, all with stage-I homologous tumors with superficial myometrial invasion. The survival rate for stage-I and -II disease at 2 years was 50% and for more advanced disease extending beyond the uterus was 0%. The survival rate for all stages at 5 years was 14.3%, and the cumulative probability of survival at 5 years was 0.165. Conclusion: The most important prognostic factors appear to be the extent of tumor involvement at the time of diagnosis and the depth of myometrial invasion. | en_US |
dc.language | eng | en_US |
dc.publisher | Elsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/ijgo | en_US |
dc.relation.ispartof | International Journal of Gynecology and Obstetrics | en_US |
dc.rights | International Journal of Gynecology & Obstetrics. Copyright © Elsevier Ireland Ltd. | - |
dc.subject | Malignant Mixed Mullerian Tumors | en_US |
dc.subject | Prognosis | en_US |
dc.subject | Uterus | en_US |
dc.title | Malignant mixed Mullerian tumors of the uterus | en_US |
dc.type | Article | en_US |
dc.identifier.email | Ngan, HYS:hysngan@hkucc.hku.hk | en_US |
dc.identifier.authority | Ngan, HYS=rp00346 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/0020-7292(94)90459-6 | en_US |
dc.identifier.pmid | 7813749 | - |
dc.identifier.scopus | eid_2-s2.0-0028168038 | en_US |
dc.identifier.hkuros | 3131 | - |
dc.identifier.volume | 47 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.spage | 39 | en_US |
dc.identifier.epage | 44 | en_US |
dc.identifier.isi | WOS:A1994PN51000007 | - |
dc.publisher.place | Ireland | en_US |
dc.identifier.scopusauthorid | To, WWK=7004294510 | en_US |
dc.identifier.scopusauthorid | Ngan, HYS=34571944100 | en_US |
dc.identifier.issnl | 0020-7292 | - |